Literature DB >> 34206743

UNC-45A Is Highly Expressed in the Proliferative Cells of the Mouse Genital Tract and in the Microtubule-Rich Areas of the Mouse Nervous System.

Valentino Clemente1, Asumi Hoshino1, Joyce Meints2, Mihir Shetty1, Tim Starr1, Michael Lee2, Martina Bazzaro1.   

Abstract

UNC-45A (Protein unc-45 homolog A) is a cytoskeletal-associated protein with a dual and non-mutually exclusive role as a regulator of the actomyosin system and a Microtubule (MT)-destabilizing protein, which is overexpressed in human cancers including in ovarian cancer patients resistant to the MT-stabilizing drug paclitaxel. Mapping of UNC-45A in the mouse upper genital tract and central nervous system reveals its enrichment not only in highly proliferating and prone to remodeling cells, but also in microtubule-rich areas, of the ovaries and the nervous system, respectively. In both apparatuses, UNC-45A is also abundantly expressed in the ciliated epithelium. As regulators of actomyosin contractility and MT stability are essential for the physiopathology of the female reproductive tract and of neuronal development, our findings suggest that UNC-45A may have a role in ovarian cancer initiation and development as well as in neurodegeneration.

Entities:  

Keywords:  UNC-45A; brain; cilia; microtubules; neurons; ovaries

Year:  2021        PMID: 34206743     DOI: 10.3390/cells10071604

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  56 in total

1.  UNC-45/CRO1/She4p (UCS) protein forms elongated dimer and joins two myosin heads near their actin binding region.

Authors:  Hang Shi; Günter Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-29       Impact factor: 11.205

2.  The phosphoprotein Op18/stathmin is differentially expressed in ovarian cancer.

Authors:  D K Price; J R Ball; Z Bahrani-Mostafavi; J C Vachris; J S Kaufman; R W Naumann; R V Higgins; J B Hall
Journal:  Cancer Invest       Date:  2000       Impact factor: 2.176

3.  UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion.

Authors:  Yoshie Iizuka; Frank Cichocki; Andrew Sieben; Fabio Sforza; Razaul Karim; Kathleen Coughlin; Rachel Isaksson Vogel; Riccardo Gavioli; Valarie McCullar; Todd Lenvik; Michael Lee; Jeffrey Miller; Martina Bazzaro
Journal:  J Immunol       Date:  2015-10-05       Impact factor: 5.422

4.  The malignancy of metastatic ovarian cancer cells is increased on soft matrices through a mechanosensitive Rho-ROCK pathway.

Authors:  Daniel J McGrail; Quang Minh N Kieu; Michelle R Dawson
Journal:  J Cell Sci       Date:  2014-04-16       Impact factor: 5.285

5.  Nonionotropic Action of Endothelial NMDA Receptors on Blood-Brain Barrier Permeability via Rho/ROCK-Mediated Phosphorylation of Myosin.

Authors:  Anupriya Mehra; Sylvaine Guérit; Richard Macrez; Fabien Gosselet; Emmanuel Sevin; Héloïse Lebas; Eric Maubert; Helga E De Vries; Isabelle Bardou; Denis Vivien; Fabian Docagne
Journal:  J Neurosci       Date:  2020-01-17       Impact factor: 6.167

Review 6.  Cancer and neurodegeneration: between the devil and the deep blue sea.

Authors:  Hélène Plun-Favreau; Patrick A Lewis; John Hardy; L Miguel Martins; Nicholas W Wood
Journal:  PLoS Genet       Date:  2010-12-23       Impact factor: 5.917

7.  NeuN As a Neuronal Nuclear Antigen and Neuron Differentiation Marker.

Authors:  V V Gusel'nikova; D E Korzhevskiy
Journal:  Acta Naturae       Date:  2015 Apr-Jun       Impact factor: 1.845

Review 8.  Primary cilia and their role in cancer.

Authors:  Michael Higgins; Ismael Obaidi; Tara McMorrow
Journal:  Oncol Lett       Date:  2019-01-17       Impact factor: 2.967

Review 9.  The cell biological basis of ciliary disease.

Authors:  Wallace F Marshall
Journal:  J Cell Biol       Date:  2008-01-07       Impact factor: 10.539

10.  UNC-45a promotes myosin folding and stress fiber assembly.

Authors:  Jaakko I Lehtimäki; Aidan M Fenix; Tommi M Kotila; Giuseppe Balistreri; Lassi Paavolainen; Markku Varjosalo; Dylan T Burnette; Pekka Lappalainen
Journal:  J Cell Biol       Date:  2017-10-20       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.